Lecture Code : CGC01-S3
Session Name : Clinical Guidelines Committee (진료지침위원회)
Session Topic : 진료지침위원회(Clinical Guidelines Committee)
Date & Time, Place : June 13 (Sat) / 15:30-17:30 / Room 4 (203), 2F

---

당뇨병콩팥병의 포괄 치료 및 합병증 관리

Geo Neul Park
Soonchunhyang University Bucheon Hospital, Republic of Korea

---

These Korean guidelines provide a comprehensive approach to diabetic kidney disease. Standardized blood pressure measurement is emphasized, with a target systolic BP <120 mmHg when tolerated. Renin–angiotensin system inhibitors are recommended as first-line therapy and titrated to maximal tolerated doses with careful monitoring. Statin-based lipid lowering is advised in non-dialysis patients. Nonsteroidal mineralocorticoid receptor antagonists offer additional cardiorenal benefits, while oral adsorbents may be considered to slow CKD progression in selected patients.

Keywords: Diabetic kidney disease, Blood pressure, Renin–angiotensin system inhibitor, Statin, Nonsteroidal mineralocorticoid receptor antagonist

그림1.png